Diabetes, ISSN 0012-1797, 06/2009, Volume 58, Issue 6, pp. 1403 - 1410
Genome-Wide Association Scan for Diabetic Nephropathy Susceptibility Genes in Type 1 Diabetes Marcus G. Pezzolesi 1 , G. David Poznik 1 , Josyf C. Mychaleckyj...
POPULATION | FERM DOMAIN | GENETICS | MEMBRANE | MICROALBUMINURIA | ENDOCRINOLOGY & METABOLISM | FOLLOW-UP | COMPLICATIONS | STAGE RENAL-DISEASE | PROGRESSION | FAMILY | Genetic Predisposition to Disease | Genome-Wide Association Study | Cytoskeletal Proteins - genetics | Membrane Proteins - genetics | Humans | Diabetes Mellitus, Type 1 - genetics | Diabetic Nephropathies - genetics | Chromosome Mapping | Diabetes Mellitus, Type 1 - complications | Proteinuria - genetics | Kidney Failure, Chronic - genetics | Polymorphism, Single Nucleotide | Genome, Human | Microfilament Proteins - genetics | Kidney - physiopathology | Type 1 diabetes | Diabetic nephropathies | Genetic aspects | Diagnosis | Kidney diseases | Diabetes | Research | Risk factors | Original
POPULATION | FERM DOMAIN | GENETICS | MEMBRANE | MICROALBUMINURIA | ENDOCRINOLOGY & METABOLISM | FOLLOW-UP | COMPLICATIONS | STAGE RENAL-DISEASE | PROGRESSION | FAMILY | Genetic Predisposition to Disease | Genome-Wide Association Study | Cytoskeletal Proteins - genetics | Membrane Proteins - genetics | Humans | Diabetes Mellitus, Type 1 - genetics | Diabetic Nephropathies - genetics | Chromosome Mapping | Diabetes Mellitus, Type 1 - complications | Proteinuria - genetics | Kidney Failure, Chronic - genetics | Polymorphism, Single Nucleotide | Genome, Human | Microfilament Proteins - genetics | Kidney - physiopathology | Type 1 diabetes | Diabetic nephropathies | Genetic aspects | Diagnosis | Kidney diseases | Diabetes | Research | Risk factors | Original
Journal Article
PLoS Genetics, ISSN 1553-7390, 02/2018, Volume 14, Issue 2, p. e1007194
Given prior evidence that an affected woman conveys a higher risk of ovarian cancer to her sister than to her mother, we hypothesized that there exists an...
X-CHROMOSOME | XIST RNA | SUSCEPTIBILITY | GENETICS & HEREDITY | INACTIVE-X | BRCA1 | MAGE-A | RISK-ASSESSMENT | HETEROZYGOSITY | ASSOCIATION | BREAST | Genetic Predisposition to Disease | Humans | Middle Aged | Male | Heredity | Paternal Inheritance - genetics | Ovarian Neoplasms - complications | Ovarian Neoplasms - epidemiology | Ovarian Neoplasms - genetics | Breast Neoplasms - complications | Breast Neoplasms - genetics | Genes, X-Linked | Pedigree | Age of Onset | Adult | Family | Female | Registries | Models, Genetic | Breast Neoplasms - epidemiology | Epigenetic inheritance | Genetic aspects | Health aspects | Ovarian cancer | Women | Haplotypes | BRCA1 protein | Funding | Genomics | Genes | Families & family life | Oncology | Breast cancer | Genomes | Disease prevention | Genetics | Software | Health risk assessment | Bioinformatics | Prostate cancer | Chromosomes | Prostate | Supervision | Age
X-CHROMOSOME | XIST RNA | SUSCEPTIBILITY | GENETICS & HEREDITY | INACTIVE-X | BRCA1 | MAGE-A | RISK-ASSESSMENT | HETEROZYGOSITY | ASSOCIATION | BREAST | Genetic Predisposition to Disease | Humans | Middle Aged | Male | Heredity | Paternal Inheritance - genetics | Ovarian Neoplasms - complications | Ovarian Neoplasms - epidemiology | Ovarian Neoplasms - genetics | Breast Neoplasms - complications | Breast Neoplasms - genetics | Genes, X-Linked | Pedigree | Age of Onset | Adult | Family | Female | Registries | Models, Genetic | Breast Neoplasms - epidemiology | Epigenetic inheritance | Genetic aspects | Health aspects | Ovarian cancer | Women | Haplotypes | BRCA1 protein | Funding | Genomics | Genes | Families & family life | Oncology | Breast cancer | Genomes | Disease prevention | Genetics | Software | Health risk assessment | Bioinformatics | Prostate cancer | Chromosomes | Prostate | Supervision | Age
Journal Article
Nature Communications, ISSN 2041-1723, 01/2017, Volume 8, Issue 1, pp. 14270 - 14270
MicroRNAs play important roles in regulating tumour development, progression and metastasis. Here we show that one of the miR-200 family members, miR-141, is...
ANDROGEN RECEPTOR | POPULATION | ZEB1 | REPRESSION | MULTIDISCIPLINARY SCIENCES | GROUP PROTEIN EZH2 | E-CADHERIN | EXPRESSION PROFILES | MESENCHYMAL TRANSITION | IDENTIFICATION | MIR-200 FAMILY | Prostatic Neoplasms - metabolism | Enhancer of Zeste Homolog 2 Protein - genetics | Enhancer of Zeste Homolog 2 Protein - metabolism | Neoplasm Invasiveness | rho GTP-Binding Proteins - genetics | Humans | Male | MicroRNAs - metabolism | Mice, SCID | Hyaluronan Receptors - genetics | Cell Movement - physiology | Animals | Neoplastic Stem Cells - metabolism | rho GTP-Binding Proteins - metabolism | Hyaluronan Receptors - metabolism | Cell Line, Tumor | Neoplasms, Experimental | Mice | MicroRNAs - genetics | Gene Expression Regulation, Neoplastic - physiology | Index Medicus
ANDROGEN RECEPTOR | POPULATION | ZEB1 | REPRESSION | MULTIDISCIPLINARY SCIENCES | GROUP PROTEIN EZH2 | E-CADHERIN | EXPRESSION PROFILES | MESENCHYMAL TRANSITION | IDENTIFICATION | MIR-200 FAMILY | Prostatic Neoplasms - metabolism | Enhancer of Zeste Homolog 2 Protein - genetics | Enhancer of Zeste Homolog 2 Protein - metabolism | Neoplasm Invasiveness | rho GTP-Binding Proteins - genetics | Humans | Male | MicroRNAs - metabolism | Mice, SCID | Hyaluronan Receptors - genetics | Cell Movement - physiology | Animals | Neoplastic Stem Cells - metabolism | rho GTP-Binding Proteins - metabolism | Hyaluronan Receptors - metabolism | Cell Line, Tumor | Neoplasms, Experimental | Mice | MicroRNAs - genetics | Gene Expression Regulation, Neoplastic - physiology | Index Medicus
Journal Article
Advanced Drug Delivery Reviews, ISSN 0169-409X, 03/2016, Volume 98, pp. 35 - 40
Treatment for solid tumor malignancies, which constitute the majority of human cancers, is still dominated by surgery and radiotherapies. This is especially...
Chemotherapy | Targeted therapy | Therapeutics | Gene therapy | Death receptors | c-FLIP | Cancer | Hormonal therapy | CHEMOKINE LIGAND 2 | ANDROGEN RECEPTOR | HUMAN MONOCLONAL-ANTIBODY | ACQUIRED-RESISTANCE | TUMOR-REGRESSION | INHIBITORY PROTEIN GENE | LUNG-CANCER | PHARMACOLOGY & PHARMACY | INCREASED SURVIVAL | RESISTANT PROSTATE-CANCER | CARLUMAB CNTO 888 | Genetic Therapy | Neoplasms - therapy | Animals | Humans | Antineoplastic Agents - therapeutic use | Combined Modality Therapy | Antineoplastic Agents - administration & dosage | Apoptosis | Antimitotic agents | Genes | Genetic aspects | Metastasis | Antineoplastic agents | Health aspects | hormonal therapy | targeted therapy | therapeutics | gene therapy | chemotherapy | death receptors
Chemotherapy | Targeted therapy | Therapeutics | Gene therapy | Death receptors | c-FLIP | Cancer | Hormonal therapy | CHEMOKINE LIGAND 2 | ANDROGEN RECEPTOR | HUMAN MONOCLONAL-ANTIBODY | ACQUIRED-RESISTANCE | TUMOR-REGRESSION | INHIBITORY PROTEIN GENE | LUNG-CANCER | PHARMACOLOGY & PHARMACY | INCREASED SURVIVAL | RESISTANT PROSTATE-CANCER | CARLUMAB CNTO 888 | Genetic Therapy | Neoplasms - therapy | Animals | Humans | Antineoplastic Agents - therapeutic use | Combined Modality Therapy | Antineoplastic Agents - administration & dosage | Apoptosis | Antimitotic agents | Genes | Genetic aspects | Metastasis | Antineoplastic agents | Health aspects | hormonal therapy | targeted therapy | therapeutics | gene therapy | chemotherapy | death receptors
Journal Article
Diabetes Care, ISSN 0149-5992, 11/2012, Volume 35, Issue 11, pp. 2311 - 2316
OBJECTIVE-Patients with diabetes have a high risk of end-stage renal disease (ESRD). We examined whether prediction of this outcome, according to chronic...
ESRD | ENDOCRINOLOGY & METABOLISM | CREATININE | CHRONIC KIDNEY-DISEASE | ASSOCIATION | EQUATION | ESTIMATING GFR | Glomerular Filtration Rate | Cystatin C - blood | Humans | Child, Preschool | Male | Diabetic Nephropathies - blood | Young Adult | Kidney Failure, Chronic - blood | Kidney Failure, Chronic - epidemiology | Adolescent | Creatinine - blood | Adult | Female | Diabetic Nephropathies - epidemiology | Child | Type 2 diabetes | Diabetics | Chronic kidney failure | Diabetic nephropathies | Development and progression | Research | Diabetes | Risk factors | Kidney diseases | Family medical history | Disease | Logistics | Original Research
ESRD | ENDOCRINOLOGY & METABOLISM | CREATININE | CHRONIC KIDNEY-DISEASE | ASSOCIATION | EQUATION | ESTIMATING GFR | Glomerular Filtration Rate | Cystatin C - blood | Humans | Child, Preschool | Male | Diabetic Nephropathies - blood | Young Adult | Kidney Failure, Chronic - blood | Kidney Failure, Chronic - epidemiology | Adolescent | Creatinine - blood | Adult | Female | Diabetic Nephropathies - epidemiology | Child | Type 2 diabetes | Diabetics | Chronic kidney failure | Diabetic nephropathies | Development and progression | Research | Diabetes | Risk factors | Kidney diseases | Family medical history | Disease | Logistics | Original Research
Journal Article
Kidney International, ISSN 0085-2538, 05/2005, Volume 67, Issue 5, pp. 1684 - 1691
Epidemic of end-stage renal disease in people with diabetes in the United States population: Do we know the cause? The number of individuals initiating renal...
antihypertensive treatments | diabetes mellitus | ACE inhibitors | end-stage renal disease (ESRD) | secular trends | USRDS | Antihypertensive treatments | End-stage renal disease (ESRD) | Secular trends | Diabetes mellitus | PROTEINURIA | PREVALENCE | TRENDS | NEPHROPATHY | BLOOD-PRESSURE | CONVERTING ENZYME-INHIBITION | UROLOGY & NEPHROLOGY | COMPLICATIONS | HYPERTENSION | IRBESARTAN | PROGRESSION | United States - epidemiology | Diabetic Nephropathies - etiology | Humans | Middle Aged | Risk Factors | Renal Replacement Therapy | Male | Diabetic Nephropathies - therapy | Kidney Failure, Chronic - therapy | Kidney Failure, Chronic - epidemiology | Kidney Failure, Chronic - prevention & control | Disease Outbreaks | Adult | Female | Aged | Diabetic Nephropathies - epidemiology | Diabetic Nephropathies - prevention & control | Kidney Failure, Chronic - etiology
antihypertensive treatments | diabetes mellitus | ACE inhibitors | end-stage renal disease (ESRD) | secular trends | USRDS | Antihypertensive treatments | End-stage renal disease (ESRD) | Secular trends | Diabetes mellitus | PROTEINURIA | PREVALENCE | TRENDS | NEPHROPATHY | BLOOD-PRESSURE | CONVERTING ENZYME-INHIBITION | UROLOGY & NEPHROLOGY | COMPLICATIONS | HYPERTENSION | IRBESARTAN | PROGRESSION | United States - epidemiology | Diabetic Nephropathies - etiology | Humans | Middle Aged | Risk Factors | Renal Replacement Therapy | Male | Diabetic Nephropathies - therapy | Kidney Failure, Chronic - therapy | Kidney Failure, Chronic - epidemiology | Kidney Failure, Chronic - prevention & control | Disease Outbreaks | Adult | Female | Aged | Diabetic Nephropathies - epidemiology | Diabetic Nephropathies - prevention & control | Kidney Failure, Chronic - etiology
Journal Article
Journal of the American Society of Nephrology, ISSN 1046-6673, 03/2012, Volume 23, Issue 3, pp. 507 - 515
Levels of proinflammatory cytokines associate with risk for developing type 2 diabetes but whether chronic inflammation contributes to the development of...
TUMOR-NECROSIS-FACTOR | MICROALBUMINURIA | RENAL-FUNCTION | MARKERS | UROLOGY & NEPHROLOGY | RISK | CORONARY-HEART-DISEASE | INFLAMMATORY CYTOKINES | NEPHROPATHY | ASSOCIATION | FACTOR-ALPHA | Predictive Value of Tests | Follow-Up Studies | Diabetic Nephropathies - etiology | Humans | Middle Aged | Male | Incidence | Diabetic Nephropathies - physiopathology | Receptors, Tumor Necrosis Factor, Type II - blood | Adult | Female | Retrospective Studies | Diabetes Mellitus, Type 2 - complications | Kidney Failure, Chronic - physiopathology | Receptors, Tumor Necrosis Factor, Type I - blood | Risk Factors | Proportional Hazards Models | Survival Rate | Biomarkers - blood | Disease Progression | Kidney Failure, Chronic - epidemiology | Signal Transduction - physiology | Aged | Diabetic Nephropathies - epidemiology | Cohort Studies | Kidney Failure, Chronic - etiology | Clinical Research
TUMOR-NECROSIS-FACTOR | MICROALBUMINURIA | RENAL-FUNCTION | MARKERS | UROLOGY & NEPHROLOGY | RISK | CORONARY-HEART-DISEASE | INFLAMMATORY CYTOKINES | NEPHROPATHY | ASSOCIATION | FACTOR-ALPHA | Predictive Value of Tests | Follow-Up Studies | Diabetic Nephropathies - etiology | Humans | Middle Aged | Male | Incidence | Diabetic Nephropathies - physiopathology | Receptors, Tumor Necrosis Factor, Type II - blood | Adult | Female | Retrospective Studies | Diabetes Mellitus, Type 2 - complications | Kidney Failure, Chronic - physiopathology | Receptors, Tumor Necrosis Factor, Type I - blood | Risk Factors | Proportional Hazards Models | Survival Rate | Biomarkers - blood | Disease Progression | Kidney Failure, Chronic - epidemiology | Signal Transduction - physiology | Aged | Diabetic Nephropathies - epidemiology | Cohort Studies | Kidney Failure, Chronic - etiology | Clinical Research
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2015, Volume 10, Issue 3, p. e0121318
PLZF is a transcription repressor, which plays a critical role in development, spermatogenesis and oncogenesis. Down-regulation of PLZF has been found in...
CELLS | GENE | SHOWS | HIGH-RISK | MULTIDISCIPLINARY SCIENCES | FISH ANALYSIS | PROLIFERATION | SUPPRESSOR PLZF | PROGRESSION | PTEN/MMAC1 | PTEN EXPRESSION | Immunohistochemistry | Lymph Node Excision | Prostatic Neoplasms - metabolism | Prostatic Neoplasms - pathology | Adenocarcinoma - pathology | Prostatic Neoplasms - surgery | Humans | Male | Disease Progression | Promyelocytic Leukemia Zinc Finger Protein | Adenocarcinoma - metabolism | Neoplasm Grading | Kruppel-Like Transcription Factors - metabolism | Neoplasm Invasiveness - pathology | Neoplasm Metastasis - pathology | Prostatectomy | Adenocarcinoma - surgery | Development and progression | Metastasis | Prostate cancer | Transcription | Spermatogenesis | Leukemia | Genomics | Genes | Lymph nodes | Metastases | Proteins | Cell growth | Cell cycle | Tumorigenesis | Bioindicators | Chromosomes | Antigens | Lymphatic system | Aggressive behavior | Review boards | Basal cells | Tumor cell lines | Molecular chains | Pathology | Androgens | Biopsy | Biomarkers | Prostate | Cancer | Apoptosis | Tumors | Lymph
CELLS | GENE | SHOWS | HIGH-RISK | MULTIDISCIPLINARY SCIENCES | FISH ANALYSIS | PROLIFERATION | SUPPRESSOR PLZF | PROGRESSION | PTEN/MMAC1 | PTEN EXPRESSION | Immunohistochemistry | Lymph Node Excision | Prostatic Neoplasms - metabolism | Prostatic Neoplasms - pathology | Adenocarcinoma - pathology | Prostatic Neoplasms - surgery | Humans | Male | Disease Progression | Promyelocytic Leukemia Zinc Finger Protein | Adenocarcinoma - metabolism | Neoplasm Grading | Kruppel-Like Transcription Factors - metabolism | Neoplasm Invasiveness - pathology | Neoplasm Metastasis - pathology | Prostatectomy | Adenocarcinoma - surgery | Development and progression | Metastasis | Prostate cancer | Transcription | Spermatogenesis | Leukemia | Genomics | Genes | Lymph nodes | Metastases | Proteins | Cell growth | Cell cycle | Tumorigenesis | Bioindicators | Chromosomes | Antigens | Lymphatic system | Aggressive behavior | Review boards | Basal cells | Tumor cell lines | Molecular chains | Pathology | Androgens | Biopsy | Biomarkers | Prostate | Cancer | Apoptosis | Tumors | Lymph
Journal Article
Molecular Cancer Research, ISSN 1541-7786, 09/2017, Volume 15, Issue 9, pp. 1138 - 1152
Tissue infiltration and elevated peripheral circulation of granulocytic myeloid-derived cells is associated with poor outcomes in prostate cancer and other...
SURVIVAL | ONCOLOGY | PROSTATE-CANCER PATIENTS | GROWTH | TISSUE | GENE-EXPRESSION PROFILES | PERIPHERAL-BLOOD | SUPPRESSOR-CELLS | EXTRACELLULAR TRAPS | TUMOR MICROENVIRONMENT | PROGRESSION | CELL BIOLOGY | Leukocyte Elastase - metabolism | Prostate - pathology | Prostatic Neoplasms - metabolism | Animals | Prostatic Neoplasms - genetics | Mice, Nude | Humans | Cell Line, Tumor | Myeloid Cells - metabolism | Male | Mice | Cell Culture Techniques | Cell proliferation | Transcription | Leukocyte migration | Serine | Lymphocytes T | Suppressor cells | Metastases | Cell activation | Xenografts | Elastase | Immune system | Peripheral circulation | Myeloid cells | Neutrophils | MAP kinase | Signaling | Depletion | Biomarkers | Infiltration | Serine proteinase | Leukocytes (granulocytic) | Prostate cancer | Prostate | Cell migration | PTEN protein | Tumors | Cancer
SURVIVAL | ONCOLOGY | PROSTATE-CANCER PATIENTS | GROWTH | TISSUE | GENE-EXPRESSION PROFILES | PERIPHERAL-BLOOD | SUPPRESSOR-CELLS | EXTRACELLULAR TRAPS | TUMOR MICROENVIRONMENT | PROGRESSION | CELL BIOLOGY | Leukocyte Elastase - metabolism | Prostate - pathology | Prostatic Neoplasms - metabolism | Animals | Prostatic Neoplasms - genetics | Mice, Nude | Humans | Cell Line, Tumor | Myeloid Cells - metabolism | Male | Mice | Cell Culture Techniques | Cell proliferation | Transcription | Leukocyte migration | Serine | Lymphocytes T | Suppressor cells | Metastases | Cell activation | Xenografts | Elastase | Immune system | Peripheral circulation | Myeloid cells | Neutrophils | MAP kinase | Signaling | Depletion | Biomarkers | Infiltration | Serine proteinase | Leukocytes (granulocytic) | Prostate cancer | Prostate | Cell migration | PTEN protein | Tumors | Cancer
Journal Article
Diabetes, ISSN 0012-1797, 12/2006, Volume 55, Issue 12, pp. 3358 - 3365
A Genome-Wide Linkage Scan for Genes Controlling Variation in Renal Function Estimated by Serum Cystatin C Levels in Extended Families With Type 2 Diabetes...
URINARY ALBUMIN EXCRETION | GLOMERULAR-FILTRATION-RATE | GFR | GENOTYPE | DISEASE | ENDOCRINOLOGY & METABOLISM | PROTEINURIA | COMPLICATIONS | CHRONIC KIDNEY | NEPHROPATHY | SUSCEPTIBILITY GENES | Diabetes Mellitus, Type 2 - genetics | Humans | Middle Aged | Reference Values | Kidney Function Tests | Chromosomes, Human, Pair 2 | Genetic Variation | Cystatin C | Adult | Glomerular Filtration Rate | Genotype | Chromosome Mapping | Chromosomes, Human, Pair 7 | Cystatins - blood | DNA - genetics | DNA - isolation & purification | Diabetes Mellitus, Type 2 - blood | Diabetes Mellitus, Type 2 - physiopathology | Cystatins - genetics | Chromosomes, Human, Pair 18 | Age of Onset | Family | Aged | Genome, Human | Chromosomes, Human, Pair 10 | Type 2 diabetes | Complications and side effects | Genetic aspects | Chronic kidney failure | Diabetic nephropathies
URINARY ALBUMIN EXCRETION | GLOMERULAR-FILTRATION-RATE | GFR | GENOTYPE | DISEASE | ENDOCRINOLOGY & METABOLISM | PROTEINURIA | COMPLICATIONS | CHRONIC KIDNEY | NEPHROPATHY | SUSCEPTIBILITY GENES | Diabetes Mellitus, Type 2 - genetics | Humans | Middle Aged | Reference Values | Kidney Function Tests | Chromosomes, Human, Pair 2 | Genetic Variation | Cystatin C | Adult | Glomerular Filtration Rate | Genotype | Chromosome Mapping | Chromosomes, Human, Pair 7 | Cystatins - blood | DNA - genetics | DNA - isolation & purification | Diabetes Mellitus, Type 2 - blood | Diabetes Mellitus, Type 2 - physiopathology | Cystatins - genetics | Chromosomes, Human, Pair 18 | Age of Onset | Family | Aged | Genome, Human | Chromosomes, Human, Pair 10 | Type 2 diabetes | Complications and side effects | Genetic aspects | Chronic kidney failure | Diabetic nephropathies
Journal Article
Cancer Research, ISSN 0008-5472, 08/2018, Volume 78, Issue 16 Supplement, pp. B043 - B043
Journal Article
Diabetes Care, ISSN 0149-5992, 06/2010, Volume 33, Issue 6, pp. 1337 - 1343
OBJECTIVE - We previously described a cross-sectional association between serum uric acid and reduced glomerular filtration rate (GFR) in nonproteinuric...
ALLOPURINOL | GLOMERULAR-FILTRATION-RATE | FUNCTION DECLINE | GFR | HYPERURICEMIA | ENDOTHELIAL DYSFUNCTION | SERIAL MEASUREMENTS | DISEASE | ENDOCRINOLOGY & METABOLISM | CYSTATIN-C | CREATININE | Glomerular Filtration Rate | Kidney - pathology | Cystatin C - blood | Albuminuria - blood | Humans | Middle Aged | Male | Diabetes Mellitus, Type 1 - complications | Disease Progression | Kidney Function Tests | Young Adult | Diabetes Mellitus, Type 1 - blood | Adolescent | Creatinine - blood | Adult | Female | Kidney Diseases - blood | Uric Acid - blood | Kidney Diseases - etiology | Albumin | Diabetics | Uric acid | Type 1 diabetes | Risk factors | Original Research
ALLOPURINOL | GLOMERULAR-FILTRATION-RATE | FUNCTION DECLINE | GFR | HYPERURICEMIA | ENDOTHELIAL DYSFUNCTION | SERIAL MEASUREMENTS | DISEASE | ENDOCRINOLOGY & METABOLISM | CYSTATIN-C | CREATININE | Glomerular Filtration Rate | Kidney - pathology | Cystatin C - blood | Albuminuria - blood | Humans | Middle Aged | Male | Diabetes Mellitus, Type 1 - complications | Disease Progression | Kidney Function Tests | Young Adult | Diabetes Mellitus, Type 1 - blood | Adolescent | Creatinine - blood | Adult | Female | Kidney Diseases - blood | Uric Acid - blood | Kidney Diseases - etiology | Albumin | Diabetics | Uric acid | Type 1 diabetes | Risk factors | Original Research
Journal Article
Journal of the American Society of Nephrology, ISSN 1046-6673, 03/2011, Volume 22, Issue 3, pp. 545 - 553
Historically, patients with type 1 diabetes and macroalbuminuria had high competing risks: cardiovascular death or renal failure. Here, we assessed these risks...
IMPROVED GRAFT-SURVIVAL | CONVERTING ENZYME-INHIBITION | MICROALBUMINURIA | TERM ANTIHYPERTENSIVE TREATMENT | UROLOGY & NEPHROLOGY | PROTEINURIA | RENAL-TRANSPLANTATION | MELLITUS | CHRONIC KIDNEY-DISEASE | NEPHROPATHY | PROGRESSION | Albuminuria - epidemiology | Diabetes Mellitus, Type 1 - epidemiology | Kidney Failure, Chronic - mortality | Albuminuria - complications | Follow-Up Studies | Comorbidity | Humans | Middle Aged | Risk Factors | Male | Survival Rate | Diabetes Mellitus, Type 1 - complications | Disease Progression | Diabetic Nephropathies - mortality | Kidney Failure, Chronic - epidemiology | Adult | Female | Diabetic Nephropathies - epidemiology | Retrospective Studies | Longitudinal Studies | Clinical Epidemiology
IMPROVED GRAFT-SURVIVAL | CONVERTING ENZYME-INHIBITION | MICROALBUMINURIA | TERM ANTIHYPERTENSIVE TREATMENT | UROLOGY & NEPHROLOGY | PROTEINURIA | RENAL-TRANSPLANTATION | MELLITUS | CHRONIC KIDNEY-DISEASE | NEPHROPATHY | PROGRESSION | Albuminuria - epidemiology | Diabetes Mellitus, Type 1 - epidemiology | Kidney Failure, Chronic - mortality | Albuminuria - complications | Follow-Up Studies | Comorbidity | Humans | Middle Aged | Risk Factors | Male | Survival Rate | Diabetes Mellitus, Type 1 - complications | Disease Progression | Diabetic Nephropathies - mortality | Kidney Failure, Chronic - epidemiology | Adult | Female | Diabetic Nephropathies - epidemiology | Retrospective Studies | Longitudinal Studies | Clinical Epidemiology
Journal Article